Existing evidence is insufficient to justify metformin or other agents as first-line therapy for type 2 diabetes

Evid Based Med. 2016 Dec;21(6):224. doi: 10.1136/ebmed-2016-110562. Epub 2016 Oct 18.

Authors

Rene Rodriguez-Gutierrez^{1

2}, Victor M Montori³

Affiliations

¹ Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota, USA.
² Division of Endocrinology, University Hospital 'Dr. Jose E. Gonzalez' Autonomous University of Nuevo Leon, Monterrey, Mexico.
³ Knowledge and Evaluation Research Unit and Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota, USA.

PMID: 27884884
DOI: 10.1136/ebmed-2016-110562

No abstract available

Publication types

Comment

MeSH terms

Diabetes Mellitus, Type 2*
Glycated Hemoglobin
Humans
Hypoglycemic Agents
Metformin*

Substances

Glycated Hemoglobin A
Hypoglycemic Agents
Metformin